TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 12064344

Group type: EXPERIMENTAL
Intervention: Green tea extract (GTE) incorporated into meat patties with a daily intake of 18.6 mg catechins/d
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control diet low in flavonoids
Number of subjects: 16
Study: 10223782

Group type: EXPERIMENTAL
Intervention: 5 mg policosanol once a day for 12 weeks
Number of subjects: 437

Group type: EXPERIMENTAL
Intervention: 10 mg policosanol once a day for the next 12 weeks
Number of subjects: 437

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 437
Study: 9048721

Group type: EXPERIMENTAL
Intervention: Gilles de la Tourette syndrome (GTS)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Obsessive-compulsive disorder (OCD)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: OCD with sensory tics
Number of subjects: 150
Study: 2037702

Group type: EXPERIMENTAL
Intervention: Guanabenz (2, 4, 8 mg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Captopril (6.25, 12.5, 25 mg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Guanabenz (8 mg) and Captopril (25 mg) concomitantly
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 6128860

Group type: EXPERIMENTAL
Intervention: Vecuronium (0.1 mg/kg)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Pancuronium
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Vecuronium (0.025 mg/kg maintenance doses)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Vecuronium
Number of subjects: 50
Study: 30642311

Group type: EXPERIMENTAL
Intervention: Mothers in Motion intervention
Number of subjects: 612

Group type: COMPARATOR
Intervention: Comparison group
Number of subjects: 612
Study: 28656921

Group type: EXPERIMENTAL
Intervention: Ketamine gargle (40 mg in 30 ml normal saline) for 30 sec, five minutes before induction of anaesthesia.
Number of subjects: 150

Group type: COMPARATOR
Intervention: Lidocaine jelly (2% applied to the ETT cuff) and 30 ml normal saline gargled for 30 sec, five minutes before induction of anaesthesia.
Number of subjects: 150
Study: 26467311

Group type: EXPERIMENTAL
Intervention: Vitamin D plus calcium supplementation (50,000 IU vitamin D3 every 2 weeks plus 1000 mg day(-1) calcium)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Vitamin D plus calcium supplementation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 23732121

Group type: EXPERIMENTAL
Intervention: Transitional care coaching intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 21706212

Group type: EXPERIMENTAL
Intervention: Forming four action plans
Number of subjects: 478

Group type: EXPERIMENTAL
Intervention: Forming five action plans
Number of subjects: 478

Group type: COMPARATOR
Intervention: Control group (questionnaires only)
Number of subjects: 478
Study: 19940978

Group type: EXPERIMENTAL
Intervention: Tension-free vaginal tape (TVT) at the time of prolapse repair (group I)
Number of subjects: 181

Group type: COMPARATOR
Intervention: Tension-free vaginal tape (TVT) 3 months after prolapse repair (group II)
Number of subjects: 181

Group type: COMPARATOR
Intervention: Prolapse surgery alone
Number of subjects: 181
Study: 17620070

Group type: EXPERIMENTAL
Intervention: Atopic keratoconjunctivitis (AKC)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Vernal keratoconjunctivitis (VKC)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Normal control subjects
Number of subjects: 48
Study: 16046582

Group type: EXPERIMENTAL
Intervention: Letrozole (2.5 mg/d) for 28 days
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 11934233

Group type: EXPERIMENTAL
Intervention: Dermatopharmacokinetic method
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Clinical trial method
Number of subjects: 130
Study: 10423764

Group type: EXPERIMENTAL
Intervention: Metoclopramide 10 mg orally 45 min before MIBI injection
Number of subjects: 47

Group type: COMPARATOR
Intervention: No metoclopramide (control)
Number of subjects: 47
Study: 7595735

Group type: EXPERIMENTAL
Intervention: FAM2 regimen (fluorouracil [5‐FU], doxorubicin, and mitomycin) administered every 43 days for seven cycles.
Number of subjects: 314

Group type: COMPARATOR
Intervention: Control group (surgery alone)
Number of subjects: 314
Study: 2403123

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate infusion (1.3%)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Sodium chloride infusion (0.9%)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control (no infusion)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Bicarbonate infusion (1.3%)
Number of subjects: 8
Study: 6968855

Group type: COMPARATOR
Intervention: Blood cardioplegia (BCP)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Crystalloid cardioplegia (KCP)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Electrolyte solution with magnesium (MgKCP)
Number of subjects: 33
Study: 31811789

Group type: EXPERIMENTAL
Intervention: Recurrent acute otitis media (AOM)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Persistent otitis media with effusion (OME)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Recurrent AOM
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Permanent hearing loss
Number of subjects: 168
Study: 31080591

Group type: EXPERIMENTAL
Intervention: Three 'Zesy002' kiwifruit
Number of subjects: 32

Group type: COMPARATOR
Intervention: Metamucil® (14.75 g, 5 g dietary fibre/d)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Metamucil®
Number of subjects: 32
Study: 28186383

Group type: EXPERIMENTAL
Intervention: 36 mg cranberry (proanthocyanidins, PAC) once daily for 10 days
Number of subjects: 272

Group type: COMPARATOR
Intervention: Placebo once daily for 10 days
Number of subjects: 272
Study: 25805285

Group type: EXPERIMENTAL
Intervention: Various apparatuses and pressure regimens used to harvest fat tissue
Number of subjects: 15
Study: 21833777

Group type: EXPERIMENTAL
Intervention: High-MUFA diet
Number of subjects: 12

Group type: COMPARATOR
Intervention: High-carbohydrate/high-fiber/low-glycemic index (CHO/fiber) diet
Number of subjects: 12
Study: 21881579

Group type: EXPERIMENTAL
Intervention: Aspirin treatment (100 mg per day)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Control group (no aspirin treatment)
Number of subjects: 164
Study: 19585102

Group type: EXPERIMENTAL
Intervention: Group A (patellar eversion)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Group B (lateral subluxation)
Number of subjects: 60
Study: 17136034

Group type: EXPERIMENTAL
Intervention: High Glycemic Index (HGI) breakfast
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Moderate Glycemic Index (MGI) breakfast
Number of subjects: 6

Group type: COMPARATOR
Intervention: Water (control)
Number of subjects: 6
Study: 15531058

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical stimulation of the abductor hallucis muscle (20 min)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no stimulation)
Number of subjects: 0
Study: 11834236

Group type: EXPERIMENTAL
Intervention: Nestorone subdermal implant (NES)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Copper T intrauterine device (T-Cu)
Number of subjects: 200
Study: 9949940

Group type: EXPERIMENTAL
Intervention: etifoxine (150‐200 mg/d)
Number of subjects: 170

Group type: COMPARATOR
Intervention: buspirone (15‐20 mg/d)
Number of subjects: 170
Study: 8310973

Group type: EXPERIMENTAL
Intervention: Amlodipine (5-10 mg once daily)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 2195596

Group type: EXPERIMENTAL
Intervention: Air insufflation in same-day studies (Group 1)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Carbon dioxide insufflation in same-day studies (Group 2)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Separate-day studies (Group 3)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Overall quality of ACBE studies in all groups
Number of subjects: 121
Study: 381073

Group type: EXPERIMENTAL
Intervention: Anti-rabies human diploid cell vaccine (HDCV)
Number of subjects: 25
Study: 31012044

Group type: EXPERIMENTAL
Intervention: 3D visualization technology
Number of subjects: 88

Group type: COMPARATOR
Intervention: CT images
Number of subjects: 88
Study: 31969307

Group type: EXPERIMENTAL
Intervention: 40 mg rosuvastatin
Number of subjects: 20
Study: 29089177

Group type: EXPERIMENTAL
Intervention: High followed by decreasing LTPA among female offspring
Number of subjects: 1408

Group type: EXPERIMENTAL
Intervention: High then decreasing LTPA among normal weight women
Number of subjects: 1408

Group type: EXPERIMENTAL
Intervention: LTSB trajectories
Number of subjects: 1408
Study: 25569817

Group type: COMPARATOR
Intervention: Alfacalcidol (1 μg/d) alone
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Alfacalcidol (1 μg/d) and raloxifene hydrochloride (60 mg/d)
Number of subjects: 76
Study: 22909294

Group type: EXPERIMENTAL
Intervention: Multisystemic therapy (MST)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Usual care with motivational interviewing (MI)
Number of subjects: 34
Study: 21350289

Group type: EXPERIMENTAL
Intervention: Continuous mode large spot transpupillary thermotherapy (LS TTT)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Standard spot sized conventional pulsed mode diode laser
Number of subjects: 5
Study: 19361801

Group type: EXPERIMENTAL
Intervention: Childbirth psychoeducation program
Number of subjects: 184

Group type: COMPARATOR
Intervention: Routine childbirth education
Number of subjects: 184
Study: 17983543

Group type: EXPERIMENTAL
Intervention: Domiciliary rehabilitation program (9-week supervised program including educational sessions, respiratory physiotherapy, and muscle training)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Domiciliary rehabilitation program
Number of subjects: 38
Study: 15298223

Group type: EXPERIMENTAL
Intervention: Perpetration of sexual violence against intimate partners in the past 10 years
Number of subjects: 1368

Group type: EXPERIMENTAL
Intervention: Factors associated with sexual violence
Number of subjects: 1368

Group type: EXPERIMENTAL
Intervention: Types of conflict associated with sexual violence risk
Number of subjects: 1368
Study: 11386488

Group type: EXPERIMENTAL
Intervention: Citalopram (7 days treatment)
Number of subjects: 15
Study: 9784910

Group type: EXPERIMENTAL
Intervention: Bisoprolol treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 7888292

Group type: EXPERIMENTAL
Intervention: Buprenorphine (3.0 to 4.5 micrograms kg‐1)
Number of subjects: 374

Group type: EXPERIMENTAL
Intervention: Diclofenac (1 mg kg‐1)
Number of subjects: 374

Group type: EXPERIMENTAL
Intervention: Fentanyl (1.5 to 2.0 micrograms kg‐1)
Number of subjects: 374

Group type: EXPERIMENTAL
Intervention: Morphine (0.1 to 0.15 mg kg‐1)
Number of subjects: 374

Group type: EXPERIMENTAL
Intervention: Nalbuphine (0.1 to 0.15 mg kg‐1)
Number of subjects: 374

Group type: EXPERIMENTAL
Intervention: Pethidine (1.0 to 1.5 mg kg‐1)
Number of subjects: 374

Group type: COMPARATOR
Intervention: Saline (as control)
Number of subjects: 374
Study: 2668252

Group type: EXPERIMENTAL
Intervention: Norfloxacin 400 mg bd
Number of subjects: 94

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94
Study: 30608521

Group type: EXPERIMENTAL
Intervention: Renal denervation (RDN)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 80
Study: 28655135

Group type: EXPERIMENTAL
Intervention: Wii-Fit
Number of subjects: 30

Group type: COMPARATOR
Intervention: Walking
Number of subjects: 30
Study: 26003919

Group type: EXPERIMENTAL
Intervention: Pressure injury prevention care bundle
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 0
Study: 23731101

Group type: EXPERIMENTAL
Intervention: Asthma clinic intervention providing education, self-monitoring promotion, regular treatment review, and written asthma action plan
Number of subjects: 0

Group type: COMPARATOR
Intervention: Current practice in asthma management in Australia
Number of subjects: 0
Study: 22126164

Group type: EXPERIMENTAL
Intervention: Detailed information on morphine (experimental group)
Number of subjects: 100

Group type: COMPARATOR
Intervention: General information on postoperative acute pain (control group)
Number of subjects: 100
Study: 19501762

Group type: EXPERIMENTAL
Intervention: Positive modelling of blue food consumption (Group A)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Negative modelling of blue food consumption (Group B)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Alone consumption (Group C)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Positive modelling (Group A)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Negative modelling (Group B)
Number of subjects: 79
Study: 16532916

Group type: EXPERIMENTAL
Intervention: Atosiban (300 microg/min)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Vasopressin (10 pmol/kg)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Ischemia markers
Number of subjects: 16
Study: 15013038

Group type: EXPERIMENTAL
Intervention: Telephonic back-up added to educational strategy
Number of subjects: 128

Group type: COMPARATOR
Intervention: Educational strategy only (Control)
Number of subjects: 128
Study: 10703628

Group type: EXPERIMENTAL
Intervention: Barrier cream
Number of subjects: 25

Group type: COMPARATOR
Intervention: Vehicle (moisturizing vehicle)
Number of subjects: 25
Study: 9109861

Group type: EXPERIMENTAL
Intervention: 4AP SR 17.5 mg bid
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 4AP SR
Number of subjects: 10
Study: 8260375

Group type: EXPERIMENTAL
Intervention: Trilostane
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Aminoglutethimide
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Both drugs
Number of subjects: 72
Study: 3898949

Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Antacids
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Continuous drip delivery
Number of subjects: 249

Group type: COMPARATOR
Intervention: Bolus delivery
Number of subjects: 249
Study: 31548595

Group type: EXPERIMENTAL
Intervention: Capsule (3000 IU/day)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Sublingual spray (3000 IU/day)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 75
Study: 30587955

Group type: EXPERIMENTAL
Intervention: O2matic-controlled treatment
Number of subjects: 20

Group type: COMPARATOR
Intervention: Manual control
Number of subjects: 20
Study: 27142676

Group type: EXPERIMENTAL
Intervention: 8-week blended care self-management program 'Partner in Balance'
Number of subjects: 80

Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 80
Study: 25336514

Group type: EXPERIMENTAL
Intervention: Standard care plus early rehabilitation
Number of subjects: 243

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 243
Study: 21399951

Group type: EXPERIMENTAL
Intervention: Antimicrobial photodynamic therapy (aPDT)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Scaling and root planing (SRP)
Number of subjects: 10
Study: 20033825

Group type: EXPERIMENTAL
Intervention: Endoscopic hemostasis with soft coagulation (Group I)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Endoscopic hemoclipping (Group II)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Both groups (Group I and Group II)
Number of subjects: 96
Study: 18677970

Group type: EXPERIMENTAL
Intervention: Test formulation of triflusal (600 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Reference formulation of triflusal (600 mg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Test formulation of HTB
Number of subjects: 24

Group type: COMPARATOR
Intervention: Reference formulation of HTB
Number of subjects: 24
Study: 16208839

Group type: EXPERIMENTAL
Intervention: Modafinil (100-400 mg) as augmentation to ongoing antidepressant therapy
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Modafinil (100-400 mg)
Number of subjects: 21
Study: 12072038

Group type: EXPERIMENTAL
Intervention: Oral soy isoflavone concentrate containing 80 mg of soy isoflavones
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 10590004

Group type: EXPERIMENTAL
Intervention: Topical ketorolac tromethamine 0.5% ophthalmic solution (Acular)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 200
Study: 8735993

Group type: EXPERIMENTAL
Intervention: Verbal rehearsal
Number of subjects: 64

Group type: COMPARATOR
Intervention: No rehearsal
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Verbal model
Number of subjects: 64

Group type: COMPARATOR
Intervention: No model
Number of subjects: 64

Group type: COMPARATOR
Intervention: Model type (for English-speaking children)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Rehearsal (for LEP children)
Number of subjects: 64
Study: 2009033

Group type: EXPERIMENTAL
Intervention: Imipramine hydrochloride
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Phenelzine sulfate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 6882984

Group type: EXPERIMENTAL
Intervention: Real ECT
Number of subjects: 70

Group type: COMPARATOR
Intervention: Sham ECT
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Follow-up at 6 months
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Treatment-resistant patients after real ECT
Number of subjects: 70
Study: 30568305

Group type: EXPERIMENTAL
Intervention: Personalized neoantigen-targeting vaccines
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable (control group not specified)
Number of subjects: 0
Study: 29457707

Group type: EXPERIMENTAL
Intervention: Effective AMPS
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo AMPS (SHAM)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 14
Study: 26387494

Group type: COMPARATOR
Intervention: Peginterferon alpha-2b monotherapy
Number of subjects: 126
Study: 24465022

Group type: EXPERIMENTAL
Intervention: Acute moderate-intensity endurance exercise
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control group (sham injection)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Both groups (exercise and control)
Number of subjects: 59
Study: 22999976

Group type: EXPERIMENTAL
Intervention: Oxytocin
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study: 18978495

Group type: EXPERIMENTAL
Intervention: High-dose apomorphine (APO)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Low-dose apomorphine (APO)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63

Group type: COMPARATOR
Intervention: Finger tapping
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Alternate foot tapping
Number of subjects: 63
Study: 17224017

Group type: EXPERIMENTAL
Intervention: Audio-tape with relevant information regarding implant insertion
Number of subjects: 98
Study: 15383887

Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin stimulating factor (rhuESF) with iron pretreatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 11165971

Group type: EXPERIMENTAL
Intervention: Clopidogrel (loading dose of 450 mg)
Number of subjects: 0
Study: 9612875

Group type: EXPERIMENTAL
Intervention: Antibiotics
Number of subjects: 86
Study: 7925227

Group type: EXPERIMENTAL
Intervention: Modified household dietary method
Number of subjects: 712

Group type: COMPARATOR
Intervention: Individual food weighing method
Number of subjects: 712
Study: 2624401

Group type: EXPERIMENTAL
Intervention: Endoscopic laser therapy
Number of subjects: 37
Study: 28990118

Group type: EXPERIMENTAL
Intervention: Fractional Er:YAG laser
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Long pulse Nd:YAG laser
Number of subjects: 33

Group type: COMPARATOR
Intervention: Both lasers
Number of subjects: 33
Study: 28212491

Group type: EXPERIMENTAL
Intervention: Upright sitting position
Number of subjects: 8

Group type: COMPARATOR
Intervention: Lying down position
Number of subjects: 8
Study: 26527790

Group type: EXPERIMENTAL
Intervention: Lapatinib (1,500 mg per day) during chemoradiotherapy and as maintenance monotherapy for 12 months
Number of subjects: 688

Group type: COMPARATOR
Intervention: Placebo during chemoradiotherapy
Number of subjects: 688

Group type: EXPERIMENTAL
Intervention: Lapatinib
Number of subjects: 688

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 688
Study: 23368904

Group type: EXPERIMENTAL
Intervention: Continuous suction mouthpiece (CSM)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Conventional mouthpiece
Number of subjects: 72
Study: 21429905

Group type: EXPERIMENTAL
Intervention: 1 Hz DCC frontal TMS
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: 3 Hz DCC frontal TMS
Number of subjects: 78

Group type: COMPARATOR
Intervention: 5 Hz DCC frontal TMS
Number of subjects: 78

Group type: COMPARATOR
Intervention: 20 Hz DCC frontal TMS
Number of subjects: 78
Study: 18652725

Group type: COMPARATOR
Intervention: No gown
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Standard gown
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Modified gown
Number of subjects: 95
Study: 17015550

Group type: EXPERIMENTAL
Intervention: Atropine, fentanyl, and mivacurium
Number of subjects: 41

Group type: COMPARATOR
Intervention: Atropine and fentanyl
Number of subjects: 41
Study: 15330327

Group type: EXPERIMENTAL
Intervention: Granulocyte-colony stimulating factor (G‐CSF) 5 microg/kg body weight per day subcutaneously
Number of subjects: 53

Group type: COMPARATOR
Intervention: Meropenem 1 g every 8 hours
Number of subjects: 53
Study: 11747004

Group type: EXPERIMENTAL
Intervention: Gadobenate dimeglumine (0.3 mmol/kg body weight, administered as three sequential bolus injections of 0.1 mmol/kg at 10-minute intervals over a 20-minute period)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Gadobenate dimeglumine (first injection)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Gadobenate dimeglumine (second injection)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Gadobenate dimeglumine (third injection)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Gadobenate dimeglumine (for patients with one lesion observed after first injection)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Gadobenate dimeglumine (for patients with one lesion observed after second injection)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Gadobenate dimeglumine (overall assessment)
Number of subjects: 74
Study: 9324704

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0